BridgeMD
New treatment option for Ischemic Stroke, Acute
Official title Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia
ClinicalTrials.gov ID: NCT06726941
What this study is testing
- What it's testing
- The aim of this study is to demonstrate the effect of routine exercise program on neuroplasticity through histone acetylation and gene expression changes in acute stroke survivors from an epigenetic perspective and to investigate the correlation of epigenetic effects with its effects on motor function and quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 70
You may be able to join if
- Participants who applied to Afyonkarahisar Health Sciences University Physical Therapy and Rehabilitation Clinic for rehabilitation purposes and had...
- Participants with ischemia as the etiology of stroke
- Participants between the ages of 25-70
- Drugs that have been used for at least 1 month and up to 6 months after a cerebrovascular accident
You likely can't join if
- Participants whose stroke etiology is other than ischemia
- Participants with clinically significant neurological disease other than stroke
- Participants with systemic and musculoskeletal diseases that will not tolerate neurological rehabilitation and prevent them from participating
The study team makes the final eligibility decision.
Where it's taking place
- Afyonkarahisar, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Afyonkarahisar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.